Head Start Annual Meeting
Please see below for further information and for future events.
Head Start Annual Meeting 2022
The fifth Head Start Annual Meeting took place on Friday 04 (eve) & Saturday 05 March 2022 at the Hilton Birmingham Metropole Hotel
This promotional meeting was organised and funded by Teva UK Limited and was open to Consultants, Nurses, GPs and other healthcare professionals from the UK and Ireland with an interest in headache and migraine.
The agenda was formulated by a Steering Committee of headache and migraine specialists, with engaging sessions and expert speakers.
This meeting was organised in accordance with England’s latest government guidance on COVID-19. All necessary safety precautions were place.
Continuing Medical Education (CME) accreditation points will be applied for from The Federation of the Royal College of Physicians and The Royal College of Nursing.
Steering Committee
Meeting Co-Chair
Professor Peter Goadsby, Professor of Neurology, King's College, London
Meeting Co-Chair
Dr Sarah Miller, Consultant Neurologist, Queen Elizabeth University Hospital, Glasgow
Steering Committee Member
Ms Susie Lagrata, Nurse Specialist, The National Hospital for Neurology and Neurosurgery, London
Steering Committee Member
Dr Richard Wood, GPwSI, Berkshire, Buckinghamshire & Oxfordshire LMC
Meeting Agenda
Friday 04 March 2022
| Time | Session | Speaker |
|---|---|---|
| 16:00-17:00 | Meeting registration, networking, and refreshments | |
| 17:00-17:15 | Co-Chair’s welcome | Professor Peter Goadsby, Professor of Neurology, King’s College London |
|
The ‘not so common’ headache disorders |
||
| 17:15-17:50 |
Cough headache |
Dr David Moreno, Clinical Research Fellow, King’s College London |
| 17:50-18:25 | Sleep circadian rhythm | Dr Alexander Nesbitt, Consultant Neurologist, Guy’s and St Thomas’ NHS Foundation Trust, London |
| 18:25-19:00 |
Pressure headache |
Professor Alexandra Sinclair, Professor of Neurology, The University of Birmingham |
|
19:00-19:30 |
Let’s hear your thoughts | Dr Sarah Miller |
| 19:30 | Co-Chair’s close | Dr Sarah Miller |
| 19:30-20:00 | Drinks reception | |
| 20:00 | Dinner | |
Saturday 05 March 2022
| Time | Session | Speaker |
|---|---|---|
| 08:30-09:00 | Meeting registration, networking, and refreshments | |
| 09:00-09:05 | Co-Chair’s welcome | Dr Sarah Miller |
|
Optimising the headache service |
||
| 09:05-09:30 | The changes in the NHS: what does this mean for headache? | Dr Niranjanan Nirmalananthan, Consultant Neurologist, St George’s University Hospitals NHS Foundation Trust, London |
| 09:30-09:55 | Self-efficacy and self-management | Dr Sophie Mitchell, Clinical Psychologist, University College London Hospitals NHS Foundation Trust |
| 09:55-10:40 | Parallel sessions A (delegates to select one workshop to attend) | |
| 1a – Empowering and educating migraine patients in Primary Care | Dr Jessica Briscoe, Guy’s and St Thomas’ NHS Foundation Trust, London | |
| 2a – Complex headache cases | Dr Farooq Maniyar, Consultant Neurologist, The Royal London Hospital, Barts Health NHS Trust | |
| 3a – Resilience and self-care for the HCP | Dr Sophie Mitchell | |
| 10:40-11:10 | Coffee break | |
| 11:10-11:45 | Parallel sessions B (delegates to select one workshop to attend) | |
|
1b – Setting up a nurse-led anti-CGRP clinic |
Ms Rebecca Stuckey, Clinical Nurse Specialist, University Hospitals Plymouth NHS Trust | |
|
2b – Headache for a Neurologist on-call |
Dr Jane Anderson, Consultant Neurologist, Cambridge University Hospitals NHS Trust | |
|
3b – Headache at the front line |
Dr David Watson, GPwSI, Hamilton Medical Group, Aberdeen |
|
|
Our real-world experience of managing patients with monoclonals |
||
|
11:45-12:15 |
The Hull experience |
Professor Fayyaz Ahmed, Consultant Neurologist, Hull University Teaching Hospitals NHS Trust |
|
12:15-12:45 |
The Glasgow experience |
Ms Lesley Murray, Lead Pharmacist for Neurosciences, Queen Elizabeth University Hospital, Glasgow |
|
12:45-13:15 |
Practical implementation and stopping |
Dr Brendan Davies, Consultant Neurologist, Royal Stoke University Hospital |
| 13.15-14.15 | Lunch | |
| Afternoon discussions | ||
|
14:15-14:45 |
What do you need vs what do I need? |
Dr Sarah Miller and Ms Susie Lagrata |
|
14:45-15:30 |
The future of headache |
Professor Peter Goadsby, Dr Sarah Miller, Ms Susie Lagrata and Dr Richard Wood |
|
15:30-15:45 |
Co-Chair’s close |
Professor Peter Goadsby |
Frequently Asked Questions
Some of the most frequently asked questions are answered below. Please click on the question to view the answer.
If you have any further questions, please do not hesitate to contact Secretariat@headstartmeeting.co.uk.
How much does this meeting cost to attend?
This meeting was free to attend.
Is this meeting CME accredited?
CME accreditation will be applied for from The Federation of the Royal College of Physicians and from The Royal College of Nursing for this meeting. If approved, the number of CME points will be awarded after the event.
Contact Us
If you have a specific question about our products or services, please use the main Teva contact us information to direct your query.
If you are reporting an adverse event or side effect relating to one of our products, please contact uk.safety@tevauk.com.
Webinar: 'Optimising Headache Pathways'
This promotional meeting is organised and funded by Teva UK Limited and open to Consultants, Nurses, GPs and other healthcare professionals from the UK and Ireland with an interest in headache and migraine
|
This meeting is open to HCPs from the UK and Ireland with an interest in headache and migraine. |
 |
|
Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX +44 (0) 1977 628500 | www.tevauk.com |
|
|
Ajovy®▼(fremanezumab) UK Prescribing Information Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or email uk.safety@tevauk.com. |
|
| Privacy Policy | Terms and Conditions | Accessibility | Reporting Adverse Events | |
